查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1826814

2025年神經診斷全球市場報告

Neurodiagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，神經診斷市場規模強勁成長，從2024年的91.7億美元增加至2025年的97.9億美元，複合年成長率為6.8%。預測期內的成長可歸因於神經系統疾病盛行率的上升、先進影像技術的普及、老年人口的成長、早期疾病診斷意識的增強、醫療基礎設施的擴展以及神經科學研發投入的增加。

預計未來幾年神經診斷市場將強勁成長，到2029年將達到126.8億美元，複合年成長率為6.7%。預測期內的成長歸因於對非侵入性診斷技術的需求不斷成長、神經系統疾病盛行率不斷上升、政府對醫療基礎設施的投資不斷增加、提高認知度和早期發現的努力，以及個人化醫療方法的擴展。預測期內的主要趨勢包括可攜式腦電圖設備的發展、人工智慧的整合以提高診斷準確性、用於腦成像的核磁共振成像技術的改進、用於持續監測的穿戴式設備的採用、神經遺傳學檢測的進步以及即時數據分析在個性化治療方案中的應用。

神經診斷學是一個專注於診斷和監測神經系統疾病（包括大腦、脊髓和周邊神經）的醫學領域。它利用先進的技術和測試來評估神經功能、檢測異常，並診斷癲癇、中風、多發性硬化症、神經病變和其他神經系統疾病。

神經診斷工具的主要類型包括診斷影像解決方案和體外診斷。診斷和影像解決方案包括旨在透過各種成像技術和診斷工具檢測健康狀況的醫療技術和服務。該領域的關鍵技術包括神經影像學、電腦斷層掃描 (CT)、磁振造影(MRI)、核子醫學影像 (PET、SPECT)、近紅外線光譜 (NIRS)、腦電圖 (EEG)、腦磁圖 (MEG)、基於體素的形態測量 (VBM) 和神經資訊學。這些診斷工具對於治療癲癇、阿茲海默症、帕金森氏症、中風、關節健康問題等至關重要，並廣泛應用於醫院、診所、診斷實驗室、影像中心和其他醫療機構。

2025 年春季美國突然提高關稅以及由此引發的貿易摩擦對醫療保健產業產生了重大影響，尤其是基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正努力應對進口手術器械、診斷影像系統以及注射器和導管等消耗品成本的上漲，其中許多產品的國內替代品有限。由於這些不斷上漲的成本給醫療保健預算帶來壓力，一些醫療機構正在推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，導致供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並尋求關鍵醫療產品的關稅豁免。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供神經診斷市場統計數據，包括全球市場規模、區域佔有率、神經診斷市場佔有率的競爭對手、詳細的神經診斷市場細分、市場趨勢和商業機會，以及在神經診斷行業取得成功所需的數據。本研究報告對神經診斷行業的現狀和未來趨勢進行了詳細分析，為您提供所需的全面觀點。

未來五年6.7%的成長預測比我們先前的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能會擾亂美國的神經系統治療，因為這會增加來自瑞典和美國的定量腦電圖 (EEG) 耳機和誘發電位測試設備的成本，從而可能危及癲癇症的診斷，並增加神經生理學實驗室的費用。由於互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響，其影響也將更加廣泛。

神經系統疾病盛行率的不斷上升預計將推動神經診斷市場的擴張。影響大腦、脊髓和神經的神經病變會導致各種認知、運動和感覺障礙。這些疾病的增加主要是由於人口老化、環境影響、生活方式改變、遺傳和診斷技術的改進等因素。神經診斷對於準確識別、評估和監測這些疾病至關重要，有助於準確診斷、明智的治療選擇和有效管理神經系統問題。例如，2023 年 4 月，美國國家醫學圖書館報告稱，670 萬美國人患有阿茲海默症，預計到 2060 年將增加到 1,380 萬。神經系統疾病盛行率的不斷上升正在推動神經診斷市場向前發展。

神經診斷市場的公司正專注於技術創新，包括先進的軟體演算法，以提高診斷準確性並改善患者預後。這些先進的演算法利用人工智慧 (AI) 和機器學習技術來處理和分析數據，從而支援更明智的決策和診斷。例如，2023 年 10 月，美國醫療設備製造商 Ceribell Inc. 推出了其 ClarityPro AI 演算法，這代表了腦電病 (ESE) 診斷領域的重大進步。這款先進的軟體與 Ceribell 腦電圖系統整合，利用機器學習分析腦電圖波形，並對疑似癲癇發作發出即時警報。 ClarityPro 是第一個獲得 FDA 批准用於獨立診斷的急性醫療設備，永續監測大腦活動並提供可操作的見解，幫助臨床醫生做出更快、更明智的治療決策。

2022年7月，專注於醫療保健領域的法國投資公司ArchiMed SAS以11億美元收購了Natus Medical Incorporated。此次收購充分利用了Natus Medical在開發用於篩檢、診斷和治療神經系統疾病的醫療設備的專業知識，鞏固了ArchiMed在神經診斷領域的地位。

神經診斷市場包括提供腦電圖 (EEG)、正子斷層掃描 (PET)、腦脊髓液 (CSF) 分析和睡眠呼吸中止症診斷等服務的營業單位所獲得的收益。市場價值還包括服務供應商銷售的或包含在其服務產品中的相關產品的價值。神經診斷市場包括經顱磁刺激 (TMS) 設備、腦磁圖 (MEG) 系統、睡眠多項生理檢查(PSG) 設備和生物感測器的銷售。該市場的價值是“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球神經學診斷：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球神經診斷市場：成長率分析
  • 全球神經診斷市場表現：規模與成長，2019-2024
  • 全球神經診斷市場預測：規模與成長，2024-2029 年，2034 年
  • 全球神經診斷：總目標市場（TAM）

第6章 市場細分

  • 全球神經診斷市場類型、績效及預測（2019-2024、2024-2029、2034）
  • 診斷和影像解決方案
  • 體外診斷
  • 全球神經診斷市場（按技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 神經影像技術
  • 電腦斷層掃描（CT）
  • 磁振造影（MRI）
  • 核子醫學掃描術診斷（PET、SPECT）
  • 近紅外光光譜成像（NIRS）
  • 腦電圖（EEG）
  • 腦磁圖（MEG）
  • 基於體素的形態測量（VBM）
  • 神經資訊學
  • 全球神經診斷市場：依疾病狀況、表現及預測，2019-2024 年、2024-2029 年、2034 年
  • 癲癇
  • 阿茲海默症
  • 帕金森氏症
  • 中風
  • 關節健康
  • 其他條件
  • 全球神經診斷市場最終用途、績效及預測（2019-2024、2024-2029、2034）
  • 醫院和診所
  • 診斷實驗室
  • 影像中心
  • 其他最終用途
  • 全球神經診斷市場：依診斷及影像解決方案細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • MRI（磁振造影）系統
  • CT（電腦斷層掃描）掃描儀
  • EEG（腦電圖）系統
  • EMG（肌電圖）系統
  • MEG（腦磁圖）系統
  • PET（正子斷層掃描）掃描儀
  • SPECT（單光子發射電腦斷層掃描）掃描儀
  • 功能性磁振造影（fMRI）系統
  • 顱內壓監測儀
  • 全球神經診斷市場：體外診斷細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 血液診斷
  • 腦脊髓液（CSF）分析
  • 基因檢測和生物標記
  • 神經化學診斷
  • 照護現場神經診斷
  • 神經退化性疾病診斷套件

第7章 區域和國家分析

  • 全球神經診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球神經診斷市場：國家、績效與預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 神經診斷市場：競爭格局
  • 神經診斷市場：公司簡介
    • Nihon Kohden Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Cephalon LLC Overview, Products and Services, Strategy and Financial Analysis
    • Stratus Neuro LLC Overview, Products and Services, Strategy and Financial Analysis
    • Cadwell Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Compumedics Limited Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Ceribell Inc.
  • CND Life Sciences Inc.
  • Lifelines Neuro Inc.
  • ANT Neuro BV
  • Neurovative Diagnostics LLC
  • Firefly Neuroscience Inc
  • IntraNerve Neuroscience Inc
  • NeuroDiagnostics Laboratories LLC
  • Advanced Brain Monitoring Inc
  • Spes Medica Srl
  • BioSignal Group Inc
  • Combinostics Inc.
  • Deymed Diagnostic LLC
  • NeuLine Health Inc.
  • Ridge Diagnostics Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年神經診斷市場：提供新機會的國家
  • 2029 年神經診斷市場：細分市場將帶來新機會
  • 2029 神經診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r33832u

Neurodiagnostics is a medical field focused on diagnosing and monitoring disorders of the nervous system, which includes the brain, spinal cord, and peripheral nerves. It utilizes advanced technologies and tests to evaluate neurological function, detect abnormalities, and help diagnose conditions such as epilepsy, stroke, multiple sclerosis, neuropathies, and other neurological diseases.

The primary types of neurodiagnostic tools are diagnostic and imaging solutions, as well as in-vitro diagnostics. Diagnostic and imaging solutions include medical technologies and services designed to detect health conditions through various imaging techniques and diagnostic tools. Key technologies in this area include neuroimaging, computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine imaging (PET, SPECT), near-infrared spectroscopic imaging (NIRS), electroencephalography (EEG), magnetoencephalography (MEG), voxel-based morphometry (VBM), and neuroinformatics. These diagnostic tools are vital for treating conditions such as epilepsy, Alzheimer's disease, Parkinson's disease, stroke, joint health problems, and more, and are used in hospitals, clinics, diagnostic laboratories, imaging centers, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The neurodiagnostic market research report is one of a series of new reports from The Business Research Company that provides neurodiagnostic market statistics, including the neurodiagnostic industry's global market size, regional shares, competitors with a neurodiagnostic market share, detailed neurodiagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the neurodiagnostic industry. This neurodiagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neurodiagnostics market size has grown strongly in recent years. It will grow from $9.17 billion in 2024 to $9.79 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rise in prevalence of neurological disorders, increase in adoption of advanced imaging technologies, growth in geriatric population, increase in awareness of early disease diagnosis, expanding healthcare infrastructure, and rise in investments in neuroscience research and development.

The neurodiagnostics market size is expected to see strong growth in the next few years. It will grow to $12.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for non-invasive diagnostic techniques, growing prevalence of neurological disorders, rising government investments in healthcare infrastructure, rising awareness and early detection initiatives, and expansion of personalized medicine approaches. Major trends in the forecast period include development of portable EEG devices, integration of AI for improved diagnostic accuracy, enhanced MRI technologies for brain imaging, adoption of wearables for continuous monitoring, advancements in neurogenetic testing, and adoption of real-time data analytics for personalized treatment plans.

The forecast of 6.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. neurological care by increasing costs for quantitative Electroencephalography(EEG) headsets and evoked potential testing equipment sourced from Sweden and China, potentially compromising seizure disorder diagnosis and raising neurophysiology lab expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of neurological disorders is expected to propel the expansion of the neurodiagnostics market. Neurological disorders, which affect the brain, spinal cord, or nerves, result in various cognitive, motor, and sensory impairments. The increase in these disorders is primarily attributed to factors such as aging populations, environmental influences, lifestyle changes, genetics, and improvements in diagnostic techniques. Neurodiagnostics are crucial for the accurate identification, assessment, and monitoring of these conditions, helping ensure precise diagnoses, informed treatment choices, and effective management of neurological issues. For instance, in April 2023, the National Library of Medicine reported that 6.7 million Americans were living with Alzheimer's disease, a number expected to rise to 13.8 million by 2060. This growing prevalence of neurological conditions is driving the neurodiagnostics market forward.

Companies in the neurodiagnostics market are focusing on technological innovations, including advanced software algorithms, to enhance diagnostic accuracy and improve patient outcomes. These sophisticated algorithms use artificial intelligence (AI) and machine learning techniques to process and analyze data, supporting better decision-making and diagnostics. For example, in October 2023, Ceribell Inc., a US-based medical equipment company, launched the ClarityPro AI algorithm, which represents a significant advancement in diagnosing electrographic status epilepticus (ESE). This advanced software, integrated with the Ceribell EEG system, uses machine learning to analyze EEG waveforms and provide real-time alerts for suspected seizures. ClarityPro is the first acute care device to receive FDA clearance for standalone diagnosis, helping clinicians make quicker, more informed treatment decisions by continuously monitoring brain activity and providing actionable insights.

In July 2022, ArchiMed SAS, a France-based investment firm focused on the healthcare sector, acquired Natus Medical Incorporated for $1.1 billion. This acquisition enhances ArchiMed's position in the neurodiagnostics space by leveraging Natus Medical's expertise in developing medical devices for screening, diagnosing, and treating neurological disorders.

Major players in the neurodiagnostics market are Nihon Kohden Corporation, Cephalon LLC, Stratus Neuro LLC, Cadwell Industries Inc., Compumedics Limited, Ceribell Inc., CND Life Sciences Inc., Lifelines Neuro Inc., ANT Neuro B.V., Neurovative Diagnostics LLC, Firefly Neuroscience Inc, IntraNerve Neuroscience Inc, NeuroDiagnostics Laboratories LLC, Advanced Brain Monitoring Inc, Spes Medica S.r.l., BioSignal Group Inc, Combinostics Inc., Deymed Diagnostic LLC, NeuLine Health Inc., Ridge Diagnostics Inc., Beacon Biosignals Inc., and Intch Inc.

North America was the largest region in the neurodiagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neurodiagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neurodiagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurodiagnostics market includes revenues earned by entities by providing services such as electroencephalography (EEG), positron emission tomography (PET), cerebrospinal fluid (CSF) analysis, and sleep apnea diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurodiagnostic market consists of sales of transcranial magnetic stimulation (TMS) devices, magnetoencephalography (MEG) systems, polysomnography (PSG) devices, and biosensors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurodiagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurodiagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurodiagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurodiagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Diagnostic And Imaging Solutions; In-Vitro Diagnostics
  • 2) By Technology: Neuroimaging Technologies; Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Nuclear Medicine Imaging (PET, SPECT); Near Infrared Spectroscopic Imaging (NIRS); Electro-Encephalography (EEG); Magneto-Encephalography (MEG); Voxel Based Morphometry (VBM); Neuroinformatics
  • 3) By Condition: Epilepsy; Alzheimer's Disease; Parkinson's Disease; Stroke; Joint Health; Other Conditions
  • 4) By End Use : Hospitals And Clinics; Diagnostic Laboratories; Imaging Centers; Other End Uses
  • Subsegments:
  • 1) By Diagnostic And Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems; CT (Computed Tomography) Scanners; EEG (Electroencephalogram) Systems; EMG (Electromyography) Systems; MEG (Magnetoencephalography) Systems; PET (Positron Emission Tomography) Scanners; SPECT (Single Photon Emission Computed Tomography) Scanners; Functional MRI (fMRI) Systems; Intracranial Pressure Monitors
  • 2) By In-Vitro Diagnostics: Blood-Based Diagnostics; Cerebrospinal Fluid (Csf) Analysis; Genetic Testing And Biomarkers; Neurochemical Diagnostics; Point-Of-Care Neurodiagnostics; Diagnostic Kits For Neurodegenerative Disorders
  • Companies Mentioned: Nihon Kohden Corporation; Cephalon LLC; Stratus Neuro LLC; Cadwell Industries Inc.; Compumedics Limited; Ceribell Inc.; CND Life Sciences Inc.; Lifelines Neuro Inc.; ANT Neuro B.V.; Neurovative Diagnostics LLC; Firefly Neuroscience Inc; IntraNerve Neuroscience Inc; NeuroDiagnostics Laboratories LLC; Advanced Brain Monitoring Inc; Spes Medica S.r.l.; BioSignal Group Inc; Combinostics Inc.; Deymed Diagnostic LLC; NeuLine Health Inc.; Ridge Diagnostics Inc.; Beacon Biosignals Inc.; Intch Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurodiagnostics Market Characteristics

3. Neurodiagnostics Market Trends And Strategies

4. Neurodiagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neurodiagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Neurodiagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Neurodiagnostics Market Growth Rate Analysis
  • 5.4. Global Neurodiagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Neurodiagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Neurodiagnostics Total Addressable Market (TAM)

6. Neurodiagnostics Market Segmentation

  • 6.1. Global Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic And Imaging Solutions
  • In-Vitro Diagnostics
  • 6.2. Global Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neuroimaging Technologies
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Nuclear Medicine Imaging (PET, SPECT)
  • Near Infrared Spectroscopic Imaging (NIRS)
  • Electro-Encephalography (EEG)
  • Magneto-Encephalography (MEG)
  • Voxel Based Morphometry (VBM)
  • Neuroinformatics
  • 6.3. Global Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Epilepsy
  • Alzheimer's Disease
  • Parkinson's Disease
  • Stroke
  • Joint Health
  • Other Conditions
  • 6.4. Global Neurodiagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Imaging Centers
  • Other End Uses
  • 6.5. Global Neurodiagnostics Market, Sub-Segmentation Of Diagnostic And Imaging Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • MRI (Magnetic Resonance Imaging) Systems
  • CT (Computed Tomography) Scanners
  • EEG (Electroencephalogram) Systems
  • EMG (Electromyography) Systems
  • MEG (Magnetoencephalography) Systems
  • PET (Positron Emission Tomography) Scanners
  • SPECT (Single Photon Emission Computed Tomography) Scanners
  • Functional MRI (fMRI) Systems
  • Intracranial Pressure Monitors
  • 6.6. Global Neurodiagnostics Market, Sub-Segmentation Of In-Vitro Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood-Based Diagnostics
  • Cerebrospinal Fluid (Csf) Analysis
  • Genetic Testing And Biomarkers
  • Neurochemical Diagnostics
  • Point-Of-Care Neurodiagnostics
  • Diagnostic Kits For Neurodegenerative Disorders

7. Neurodiagnostics Market Regional And Country Analysis

  • 7.1. Global Neurodiagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Neurodiagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neurodiagnostics Market

  • 8.1. Asia-Pacific Neurodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neurodiagnostics Market

  • 9.1. China Neurodiagnostics Market Overview
  • 9.2. China Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neurodiagnostics Market

  • 10.1. India Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neurodiagnostics Market

  • 11.1. Japan Neurodiagnostics Market Overview
  • 11.2. Japan Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neurodiagnostics Market

  • 12.1. Australia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neurodiagnostics Market

  • 13.1. Indonesia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neurodiagnostics Market

  • 14.1. South Korea Neurodiagnostics Market Overview
  • 14.2. South Korea Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neurodiagnostics Market

  • 15.1. Western Europe Neurodiagnostics Market Overview
  • 15.2. Western Europe Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neurodiagnostics Market

  • 16.1. UK Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neurodiagnostics Market

  • 17.1. Germany Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neurodiagnostics Market

  • 18.1. France Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neurodiagnostics Market

  • 19.1. Italy Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neurodiagnostics Market

  • 20.1. Spain Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neurodiagnostics Market

  • 21.1. Eastern Europe Neurodiagnostics Market Overview
  • 21.2. Eastern Europe Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neurodiagnostics Market

  • 22.1. Russia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neurodiagnostics Market

  • 23.1. North America Neurodiagnostics Market Overview
  • 23.2. North America Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neurodiagnostics Market

  • 24.1. USA Neurodiagnostics Market Overview
  • 24.2. USA Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neurodiagnostics Market

  • 25.1. Canada Neurodiagnostics Market Overview
  • 25.2. Canada Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neurodiagnostics Market

  • 26.1. South America Neurodiagnostics Market Overview
  • 26.2. South America Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neurodiagnostics Market

  • 27.1. Brazil Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neurodiagnostics Market

  • 28.1. Middle East Neurodiagnostics Market Overview
  • 28.2. Middle East Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neurodiagnostics Market

  • 29.1. Africa Neurodiagnostics Market Overview
  • 29.2. Africa Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neurodiagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Neurodiagnostics Market Competitive Landscape
  • 30.2. Neurodiagnostics Market Company Profiles
    • 30.2.1. Nihon Kohden Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Cephalon LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Stratus Neuro LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Cadwell Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Compumedics Limited Overview, Products and Services, Strategy and Financial Analysis

31. Neurodiagnostics Market Other Major And Innovative Companies

  • 31.1. Ceribell Inc.
  • 31.2. CND Life Sciences Inc.
  • 31.3. Lifelines Neuro Inc.
  • 31.4. ANT Neuro B.V.
  • 31.5. Neurovative Diagnostics LLC
  • 31.6. Firefly Neuroscience Inc
  • 31.7. IntraNerve Neuroscience Inc
  • 31.8. NeuroDiagnostics Laboratories LLC
  • 31.9. Advanced Brain Monitoring Inc
  • 31.10. Spes Medica S.r.l.
  • 31.11. BioSignal Group Inc
  • 31.12. Combinostics Inc.
  • 31.13. Deymed Diagnostic LLC
  • 31.14. NeuLine Health Inc.
  • 31.15. Ridge Diagnostics Inc.

32. Global Neurodiagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurodiagnostics Market

34. Recent Developments In The Neurodiagnostics Market

35. Neurodiagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Neurodiagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Neurodiagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Neurodiagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer